SBC Medical Group Holdings (SBC) Current Deferred Revenue (2023 - 2025)
SBC Medical Group Holdings filings provide 3 years of Current Deferred Revenue readings, the most recent being $1.4 million for Q4 2025.
- On a quarterly basis, Current Deferred Revenue fell 87.94% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 87.94% decrease, with the full-year FY2025 number at $1.4 million, down 87.94% from a year prior.
- Current Deferred Revenue hit $1.4 million in Q4 2025 for SBC Medical Group Holdings, up from $1.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $23.1 million in Q4 2023 to a low of $565495.0 in Q3 2024.
- Median Current Deferred Revenue over the past 3 years was $10.2 million (2025), compared with a mean of $8.3 million.
- The widest YoY moves for Current Deferred Revenue: up 82.21% in 2025, down 87.94% in 2025.
- SBC Medical Group Holdings' Current Deferred Revenue stood at $23.1 million in 2023, then plummeted by 49.09% to $11.7 million in 2024, then crashed by 87.94% to $1.4 million in 2025.
- The last three reported values for Current Deferred Revenue were $1.4 million (Q4 2025), $1.0 million (Q3 2025), and $10.3 million (Q2 2025) per Business Quant data.